Purpose: Because data from randomized trials initiated after the introduction of prostate
specific antigen testing are unavailable, we performed a retrospective, population based …

Prostate cancer is the third most common diagnosed malignancy. It is a heterogeneous
disease with incidence rates that vary substantially across the world, from 6.3 to 83.4 per …

Prostate cancer has emerged as the most frequent cancer amongst men in Europe, with
incidence increasing rapidly over the past two decades. Incidence has been uniformly …

Background Over the past decade prostate cancer (PCa) diagnostic approaches have
evolved away from aggressive prostate-specific antigen (PSA) screening. While a goal of …

Objectives: Trends in first-time and later PSA procedure rates are ascertained using
longitudinal data from a population-based cohort. These trends are compared to trends in …

Introduction: Prostate cancer is one of the tumors with higher incidence and mortality among
men in the World. Epidemiological data are influenced by life expectancy of population …

Purpose In the era of widespread prostate specific antigen (PSA) screening, a large
proportion of older men have to live with a diagnosis of prostate cancer. In this study, we …

This paper presents prostate cancer incidence and mortality rates in the United States by
factors associated with the disease at diagnosis and explores racial differences in these …

INTRODUCTION: Prostate cancer is the leading cancer in US men, and the third leading
cause of cancer deaths. Principal screening tests for detection of asymptomatic prostate …

Purpose: Before this study, the highest reported incidence of prostate cancer in the world
was thought to be among United States black men. The age adjusted rates in 1992 for …